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The use of Serious Games (SG) in the health domain is expanding. In the field
of neurodegenerative disorders (ND) such as Alzheimer’s disease, SG are currently
employed both to support and improve the assessment of different functional and
cognitive abilities, and to provide alternative solutions for patients’ treatment, stimulation,
and rehabilitation. As the field is quite young, recommendations on the use of SG in
people with ND are still rare. In 2014 we proposed some initial recommendations (Robert
et al., 2014). The aim of the present work was to update them, thanks to opinions
gathered by experts in the field during an expert Delphi panel. Results confirmed that
SG are adapted to elderly people with mild cognitive impairment (MCI) and dementia,
and can be employed for several purposes, including assessment, stimulation, and
improving wellbeing, with some differences depending on the population (e.g., physical
stimulation may be better suited for people with MCI). SG are more adapted for use
with trained caregivers (both at home and in clinical settings), with a frequency ranging
from 2 to 4 times a week. Importantly, the target of SG, their frequency of use and the
context in which they are played depend on the SG typology (e.g., Exergame, cognitive
game), and should be personalized with the help of a clinician.
Keywords: serious games, neurodegenerative disorders, recommendations, ICT, Delphi Technique
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INTRODUCTION
The use of Information and Communication Technologies (ICT)
in the health domain is progressively expanding. Recently,
increasing attention is devoted to the field of neurodegenerative
disorders (ND), such as Alzheimer’s disease (AD), where ICT
is employed both to support and improve the assessment
of different functional and cognitive abilities (Aalbers et al.,
2013; Robert et al., 2013; König et al., 2015), and to provide
alternative solutions for patients’ treatments, stimulation, and
rehabilitation. A field which is rapidly growing is that of Serious
Games (SG), which are mental and/or physical contests played
with a computer in accordance with specific rules, which use
entertainment to promote training, education, health, public
policy, and strategic communication objectives (Zyda, 2005).
Contrary to other ICT-based tools, such as computerized testing
or cognitive training, SG embed the playful and entertaining
aspects typical of video-games into the ‘serious’ activity, by
applying a pedagogic scenario to the game scenario (Alvarez,
2007). The features typical of SG, such as the presence
of a game challenge and of long-term goals, have been
proposed to make SG more adapted than classical computer-
based training to sustain generalization of learnt activities
to real life situations (Whyte et al., 2015). For this reason,
recommendations for the design of SG targeting ND are starting
to emerge (e.g., Bouchard et al., 2012; Fua et al., 2013; Mader,
2015). However, recommendations on the use of SG in these
populations are still rare. In 2014, we proposed some initial
recommendations for the use of SG in people with ND, gathered
by experts in the field during a consensus group (Robert et al.,
2014). Specifically, we systematically analyzed the Strengths,
Weaknesses, Opportunities and Threats (SWOT) of employing
SG with these patients, and reported practical guidelines on
when, where, and with whom SG should be employed, and to
specify which categories of patients and which abilities should
be targeted. Since then, a few empirical studies were published
on the use of SG in these populations, describing the feasibility
of employing SG targeting improvements in social/emotional
wellbeing (Beneviste et al., 2012), SG training cognitive abilities
such as executive functions (Manera et al., 2015), and Serious
Exergames including a combination of cognitive training and
physical training (Ben-Sadoun et al., 2016). A few more SG were
designed for these patients to train cognitive abilities such as
memory (Kim et al., 2015) and several aspects of visual attention
(Mader et al., 2012), but they have not been tested so far on people
with ND. Based on these new works and on the experience gained
by different research centers involved in the use of SG in people
with ND in the last years (e.g., the CoBTeK research laboratory
of the Université Côte d’Azur, France; the Hopital Broca in
Paris, France; the Radboud Alzheimer Center, Nijmegen, the
Netherlands; Neuroscape in San Francisco, CA, United States)
the aim of the present work is to update the recommendations
published in 2014, thanks to a Delphi expert panel.
Neurodegenerative Disorders (ND)
ND progress through several stages in several years, and
ultimately lead to dementia, a decline in mental ability severe
enough to interfere with activities of daily living. Dementia
can result from different causes, the most common being
AD. It is often preceded by a pre-dementia stage, known as
mild cognitive impairment (MCI), characterized by a cognitive
decline greater than expected for an individual’s age, which,
however, does not interfere notably with activities of daily
living (Petersen et al., 1997). Depending on the etiology and
the disease’s stage, dementia can be characterized by cognitive,
behavioral, motor, and/or functional symptoms. The biological
processes involved in ND are very heterogeneous, and include
neuroinflammation, gliosis, synaptic loss, neurodegeneration,
cerebral atrophy, and alterations of the blood–brain barrier
permeability (Raz et al., 2016). These molecular alterations
are due, among others, to alterations in the bioenergy
metabolism, to hypoperfusion/hypoxia, and to dysfunctions of
the cerebrovascular hemodynamic. From a therapeutic point of
view, much research aims to modify the course of the disease or
to reduce the impact of the clinical symptoms. Social interaction,
physical and cognitive activities, and motivation can have a major
impact on the disease progression. Hence, non-pharmacological
approaches targeting people’s lifestyle are of particular interest.
Serious Games for People with
Neurodegenerative Disorders
Boosted by the publication of a Nature letter showing that
video game training can enhance cognitive control in older
adults (Anguera et al., 2013), there is now a growing interest in
developing SG specifically adapted to people with ND. Evidence
is accumulating showing that video-games and VR-applications
can successfully be employed for early detection and monitoring
of physical and cognitive impairment (e.g., Tarnanas et al., 2013;
Aalbers et al., 2016; Negut et al., 2016; Zygouris et al., 2017),
but also to train physical and cognitive abilities in people with
AD, MCI, and related disorders. In the field of training, most
of the research work so far has been conducted employing
commercial video-games and cognitive games (such as Wii Fit
and Wii Sport, Lumosity) designed for an entertaining purpose,
and with a ‘typical’ healthy user in mind. In their review on the
use of video-games in people with dementia-related disorders,
McCallum and Boletsis (2013) showed that: (a) Exergames, i.e.,
games that promote physical condition and/or aerobic fitness can
positively affect several areas of mobility in participants with mild
AD and MCI, such as balance and gait (Padala et al., 2012), and
voluntary motor control (Legouverneur et al., 2011); (b) cognitive
games can improve cognitive functions, such as attention and
memory (Stavros et al., 2010; Weybright et al., 2010) and visuo-
spatial abilities (Yamaguchi et al., 2011); (c) physical and cognitive
games can have a positive impact on social and emotional
functions, for instance they can improve the mood and increase
positive affect and sociability (Weybright et al., 2010; Boulay et al.,
2011) and reduce depression (Férnandez-Calvo et al., 2011). As
the field is young, less evidence is available on the efficacy of
SG specifically designed for the training of people with ND.
However, evidence collected in three studies suggests that SG
and Serious Exergames are acceptable and motivating even for
people with dementia. Beneviste et al. (2012) designed a SG
based on musico-therapy targeting patients with AD and mild
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to moderate dementia aiming at improving patients’ self-image
and to reduce their behavioral symptoms. Players use Wiimotes
with WiiPistol to improvise or play predefined songs on a virtual
keyboard. Results of a 2-month usability study conducted on
seven AD patients confirmed that the SG was usable by AD
patients despite their motor and cognitive impairments, and that
patients were overall very satisfied with the game and expressed
a desire to repeat the experience. Manera et al. (2015) found
similar results with ‘Kitchen and cooking,’ a SG designed to train
executive functions and praxis in people with MCI and early
AD. The results of a 4-week feasibility study conducted on 21
participants (with MCI or early to moderate AD) confirmed
that the game was acceptable and usable both at home and in
a nursing home setting, and that patients were able to improve
their game performance over the training, as confirmed by the
fact that they became faster in the game activities. Finally, Ben-
Sadoun et al. (2016) showed that X-Torp, a Serious Exergame
designed to train physical, cognitive and social functions, was
well accepted by people with dementia and MCI (N = 10) and
healthy elderly controls (N = 8), and that during a 1-month trial
participants experienced mainly positive emotions, improved
their cardio-respiratory fitness, and were able to progress in
the cognitive games scenarios. A summary of the training
features of these three feasibility/pilot studies in reported in
Table 1.
Data on the frequency of use employed in the three feasibility
studies is converging with the recommendations reported by
Robert et al. (2014). A consensus group including expert of
ND (health domain) and of VG/SG design (ICT domain)
and commercialization (business domain) met in a standalone
meeting, and were asked to respond to questions concerning
the ideal clinical population and target of SG, their frequency of
use, and their context of use (with whom and where). Results
(reported in Figure 1) suggested that: (a) SG were considered
between ‘adapted’ and ‘very adapted’ to people with MCI, and
between ‘not very adapted’ and ‘adapted’ to people with AD
and related disorders; (b) SG was rated between ‘adapted’ and
‘very adapted’ for assessment, stimulation and rehabilitation of
people with AD and related disorders, to train family caregivers
and healthcare professionals, with the best rated target being
stimulation; clinical targets rated between ‘adapted’ and ‘very
adapted’ included physical, cognitive and social stimulation, as
well as apathy (while agitation and improvements in activities
of daily living were considered between ‘not very adapted’ and
‘adapted’); (c) SG should be employed regularly (‘everyday’ and
‘once a week’ were both rated between ‘adapted’ and ‘very
adapted,’ while ‘on request’ was rated between ‘not very adapted’
and ‘adapted’); (d) SG were rated between ‘adapted’ and ‘very
adapted’ to be employed at home, in day centers and nursing
homes, and between ‘not very adapted’ and ‘adapted’ to be
employed in the hospital; (e) SG were rated between ‘adapted’
and ‘very adapted’ to be employed with someone (being either
a therapist, a family caregiver or a professional caregiver), and
between ‘not very adapted’ and ‘adapted’ to be employed alone
(or with a robot).
In the present paper we aimed to update and refine these initial
recommendations thanks to a Delphi expert panel. A number of
methodological changes were performed compared to the 2014
TABLE 1 | Summary of the existing studies on SG tested on participants with MCI and/or dementia.
MinWii Kitchen and cooking X-Torp
Feasibility study Beneviste et al., 2012 Manera et al., 2015 Ben-Sadoun et al., 2016
SG for whom? Older adults with AD and
mild to severe dementia
Older adults with MCI and
mild to moderate dementia
Older adults with MCI and
mild to moderate dementia
What is the clinical target? Increase self-esteem;
reduce behavioral
symptoms
Train executive functions
(e.g., planning) and praxis
Train physical and cognitive
activity in a positive
emotional context
Where was it used? Clinical setting Clinical setting, home,
nursing home
Clinical setting
With whom was it used? Clinician and by groups of
3–4 participants
Clinician and alone Clinician
When (how frequently) was it used? Once a week Once a week in a clinical
setting; As much as they
wanted at home/nursing
home
3 times/week
Training duration 4–8 weeks 4 weeks 5 weeks
Session duration Mean of 10-20 min As much as wanted Mean 35–40 min
Number of participants 7 21 (MCI and ND) 18 (10 ND, 8 controls)
Participants’ clinical baseline data MMSE between 10 and 25 For AD, MMSE between 15
and 24: for MCI, MMSE
between 24 and 30
For ND, MMSE between 16
and 27, CDR > 0
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FIGURE 1 | Results of the recommendations for the use of SG drafted in the
2013 IA workshop. Adapted from Robert et al. (2014). In a Delphi panel,
participants were provided with questions concerning the ideal clinical
population and target of SG (light gray bars). Next they were asked to focus
on older adults with cognitive impairment, and were asked questions about
the clinical target, the frequency of use, and the context of use (with whom
and where) of SG in this population (dark gray bars). For each question,
participants were provided with a number of response alternatives, and asked
to rate each item on a 4-point scale, from ‘not adapted at all’ to ‘completely
adapted.’
consensus panel. First of all, the 2014 recommendations were
collected in a single round, without following the classical Delphi
methodology. Indeed in the standard Delphi method (Linstone
and Turoff, 1975) experts are asked to answer questions in two
(or more) rounds. After each round, a facilitator provides a
summary of the experts’ responses, and encourages the experts
to analyze, comment and (eventually) revise their earlier answers
in light of the commentaries of other members of the panel.
The recommendations reported in the present paper followed the
classical Delphi method (see below). Second, in 2014 we asked
participants to rate each question on a 4-point scale (‘not adapted
at all,’ ‘not very adapted,’ ‘adapted’ and ‘very adapted’). Here, we
selected instead a 5-point scale (‘not adapted at all,’ ‘not very
adapted,’ ‘adapted,’ ‘very adapted’ and ‘completely adapted’) to
improve the symmetry of this Likert-type scale. Third, in the 2014
study several questions collapsed persons with MCI and more
advanced stages of AD (‘people with AD and related disorders’).
As recommendations for these two groups may be quite different,
in the present study we kept them as separated categories for
all the questions. Forth, we collapsed in a single questions
the ‘Where’ and ‘With whom’ questions (see below), in order
to better explore the exact contributions of (and interactions
between) these two factors. Finally, we added a number of
response alternatives to several questions, in order to obtain more
precise information (e.g., in the ‘When’ question, we employed 6
response alternatives instead of 3).
METHODS
The recommendations reported in the present paper were
collected and discussed during the workshop “Innovation
Alzheimer 2016,” organized by the CoBTeK (Cognition –
Behaviour – Technology) Research Unit of the Université Côte
d’Azur, in Nice (France) on September 28th, 2016, in occasion of
the 10th World Conference of Gerontechnology (ISG2016).
Participants
The expert panel (N = 23) included researchers and health care
professionals working on autism and other neurological and
developmental disorders (n = 6), neurodegenerative disorders
(n = 10), or both neurodevelopmental and neurodegenerative
disorders (n = 2); ICT engineers (n = 2); and game developers
(n= 3).
Procedure
Following the DELPHI method, a list of questions was sent
to all participants a week before the meeting via web-survey.
Who, Where, When, and What questions were used as guidelines
to structure the survey. Specifically, participants were asked to
respond to the following questions:
(a) SG for whom? Are SG adapted (i.e., appropriate) to the
following populations?
• Mild Cognitive Impairment (MCI);
• Early to moderate dementia due neurodegenerative
disorders such as AD (dementia)
(b) What is the clinical target (in each condition)?
• Assess (Physical, cognitive functions, IADL, . . .)
• Train physical activity (Muscles, cardio-resp. fitness)
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• Train cognitive functions (Attention, memory,
executive functions,. . .)
• Improve autonomy (IADL)
• Improve wellbeing (Increase positive emotions, self-
esteem; reduce negative emotions, stress)
• Favor social exchanges (Improve sociability and favor
relations)
• Teach contents
(c) Where should SG be used, and with whom (in each
condition)?
• At home, alone
• In a clinical facility (e.g., hospital, long-term residence,
at the doctor’s office), alone
• At home, with a trained (professional or family)
caregiver
• In a clinical facility, with a trained (professional or
family) caregiver
(d) When (how frequently) should SG be used (in each
condition)?
• Once a week
• Twice a week
• 3 times a week
• 4 times a week
• 5 times a week
• Everyday
Participants were asked to rate each item on a 1–5 scale
(1 = not adapted at all; 2 = not very adapted; 3 = adapted;
4= very adapted; 5= completely adapted).
DATA ANALYSIS
Results were collected, and analyzed. During the workshop, a
discussion session was organized with the objective to comment
on the survey results, and to generate practical recommendations
for the use of SG in MCI and dementia. Ratings from one
participant were not considered for data analysis because more
than 50% of responses were missing. Thus, reported data
refer to 22 participants. For descriptive analysis purposes, we
reported mean ratings. In order to compare ratings obtained
for people with MCI and people with dementia in the first
(“SG for whom?”) and second (“What is the clinical target?”)
questions, we performed separate repeated-measures ANOVAs
on each response item with Group (MCI vs. dementia) as within
subject factor. For the second question, in order to account
for multiple comparisons (N = 7), Bonferroni corrections were
applied (α= 0.05/7= 0.007). The third question (“Where should
SG be used, and with whom”) was analyzed by means of a
repeated-measures ANOVA with Group (MCI vs. dementia),
Where (home vs. clinical facility) and with Whom (alone vs. with
a trained caregiver) as within-subject factors, in order to analyze
the effect of the three factors and their interactions. Finally, the
fourth question (“When should SG be used?”) was analyzed by
means of a repeated-measures ANOVA with Group (MCI vs.
dementia) and Frequency (1, 2, 3, 4, 5 and 7 days per week)
as within-subject factors. As the methodology employed in the
present study is not completely comparable to that employed in
the 2014 recommendations paper, we compared the results of the
two studies only at a descriptive level.
RESULTS
SG for Whom?
Results are reported in Figure 2A. SG were rated between ‘very
adapted’ and ‘completely adapted’ for people with MCI, and
between ‘adapted’ and ‘very adapted’ to people with dementia.
Repeated-measures ANOVA confirmed that SG were rated as
more adapted to people with MCI compared to people with
dementia [F(1,21) = 16.87, p = 0.001], suggesting that SG are
considered as more adapted to people with initial cognitive
decline than to people which are already loosing autonomy
in activities of daily living. However, SG are considered to be
adaptable also to people with dementia.
What Is the Clinical Target?
Results are reported in Figure 2B. Participants reported that
SG are between ‘very adapted’ and ‘completely adapted’ for
assessment, to train physical and cognitive functions, improve
wellbeing, and teach contents. Improving autonomy and favoring
social exchanges were considered from ‘adapted’ to ‘very adapted.’
For people with dementia, SG were rated between ‘adapted’ and
‘very adapted’ for all the specified targets. This is in line with
responses to the question ‘SG for whom,’ and it suggests that
all these domains do represent useful targets for SG in this
population. Repeated-measures ANOVAs (Bonferroni corrected)
conducted to compare people with MCI and dementia for
each category suggested that SG were considered as more
adapted to people with MCI compared to people with dementia
to train cognitive functions [F(1,20) = 17.44, p < 0.001], to
improve autonomy [F(1,20) = 10.80, p = 0.004] and wellbeing
[F(1,21) = 9.32, p= 0.006] and to teach contents [F(1,20) = 15.42,
p = 0.001]. All the other contrasts did not reach statistical
significance (p> 0.007).
Where Should SG Be Used, and with
Whom?
Results for all these patient populations (Figure 2C) suggest that
SG are mostly adapted (between ‘very adapted’ and ‘completely
adapted’) to be employed with a trained caregiver, both in
a home and in a clinical setting. The use of SG by patients
alone was rated between ‘adapted’ and ‘very adapted’ for people
with MCI, and between ‘not very adapted’ and ‘adapted’ for
people with dementia. Repeated-measures ANOVA with Group
(MCI vs. dementia), Where (home vs. clinical facility) and
With whom (alone vs. with a trained caregiver) as within-
subject factors confirmed a significant effect of With whom factor
[F(1,19) = 54.82, p< 0.001], with SG use with a caregiver as more
adapted compared to SG use alone. The Where factor was not
statistically significant [F(1,19) = 1.30, p= 0.269], thus suggesting
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FIGURE 2 | Results of the rating questions. Error bars represents 95% Confidence Intervals for the ANOVAs. ∗Reported in (A,B) show significant paired contrasts in
the repeated-measures ANOVA with Group (MCI vs. Dementia) as within-subject factor. (A) SG for whom? Are SG adapted to older people: with MCI; and early to
moderate dementia due neurodegenerative disorders (dementia); (B) What is the clinical target? Assess; train physical activity; train cognitive functions; improve
autonomy; Improve wellbeing; favor social exchanges; teach contents. (C) Where should SG be used, and with whom? At home, alone; in a clinical facility, alone; at
home, with a trained caregiver; in a clinical facility, with a trained caregiver. (D) When (how frequently) should SG be used? 1, 2, 3, 4, 5, and 7 days per week.
that SG are considered as equally adapted to be employed at
home and in a clinical facility. A significant effect of Group was
also found, with SG rated as more adapted to be employed with
people with MCI compared to people with dementia in all the
settings [F(1,19) = 22.03, p < 0.001]. Interestingly, a significant
interaction between Group and With whom factor was also
found [F(1,19) = 12.67, p= 0.002], suggesting that employing SG
with a trained caregiver is especially important for people with
dementia. No other 2-way or 3-way interaction reached statistical
significance (all ps > 0.360).
When (How Frequently) Should SG Be
Used?
Results (Figure 2D) suggest that all the game frequencies
were rated between ‘adapted’ and ‘completely adapted’ for
all conditions, and the mean ratings of the different game
frequencies can be visually described as skewed Gaussian
distributions. Repeated-measures ANOVA with Group
(MCI vs. dementia) and Frequency (1, 2, 3, 4, 5 and 7 days
per week) as within-subject factors revealed no significant
main effect of Group [F(1,18) = 3.45, p = 0.008], and Frequency
[F(5,90) = 1.72, p= 0.139], and no significant interaction between
Group and Frequency [F(5,90) = 0.60, p = 0.704]. Converging
with descriptive data, the ANOVA’s contrast tests revealed an
almost-significant quadratic contrast [F(1,18) = 4.27, p = 0.053],
suggesting that categories in the middle of the curve were rated
as more adapted compared to extreme values (1 and 7 days per
week). For participants with MCI and dementia, the highest
scores were obtained for game frequencies from 2 to 4 days a
week.
DISCUSSION
Since the publication of our previous recommendations on
the use of SG (Robert et al., 2014), a number of SG were
developed and tested with older people with MCI and dementia
to train physical and cognitive abilities and to improve emotional
wellbeing (Beneviste et al., 2012; Manera et al., 2015; Ben-Sadoun
et al., 2016). These studies showed promising results, but also a
number of usability challenges. Reported difficulties included, for
instance, a higher fatigability of people with MCI and dementia
in physically stimulating SG compared to healthy older adults
(Ben-Sadoun et al., 2016), and, for several participants with
cognitive impairment, low motivation to play SG when not
accompanied by a family or professional caregiver (Manera
et al., 2015). These difficulties were reported despite these SG
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were specifically designed for people in these populations. This
suggests that the feasibility of employing SG with people with ND
does not depend only on the game design features: an important
component is the training format and structure. This confirms
the importance of providing recommendations not only for the
design, but also on the use of SG, that should be tested in clinical
trials. Starting from the recommendations published in 2014
(Robert et al., 2014), the aim of the present paper was to draft
guidelines for the use of SG in people with ND, thanks to a review
of recently published studies employing SG in these populations,
and gathering the opinion of experts in the field in a Delphi expert
panel. A summary of the main recommendations is reported in
Table 2.
SG for Whom?
Serious Games were rated as more adapted to people with MCI
compared to people with dementia. The results are converging
with those reported in our previous recommendations (SG were
considered between ‘adapted’ and ‘very adapted’ to people with
MCI, and between ‘not very adapted’ and ‘adapted’ to people with
AD and related disorders; Robert et al., 2014), and suggest that SG
may be more useful for people with initial cognitive decline than
to people which are already loosing autonomy in activities of daily
living. This can be explained, on one hand, by the recognition that
the cognitive decline associated to dementia (working memory,
attention, etc.) makes it more challenging to design and employ
SG in this population; and on the other hand, by the recognition
that early interventions targeting initial cognitive decline are
supposed to be more effective compared to late interventions
(Barnett et al., 2014). Anyway, SG are considered as adaptable
also to people with dementia. This is confirmed by recent studies
showing that SG are usable in people with dementia both when
TABLE 2 | Recommendations for the use of SG in people with neurodegenerative
disorders in a nutshell.
Are SG adapted to whom?
- SG are completely adapted to older people with MCI;
- Designing SG for people with dementia is challenging, but important.
What should be the SG target?
- Assessment, training and promoting wellbeing are good targets for people
with MCI and dementia
- For MCI, SG for physical and cognitive stimulation are particularly suitable;
- SG choice should be personalized based on clinical assessment aiming at
identifying training targets in different domains.
Where should SG be used, and with whom?
- SG can be employed both at home and in clinical facilities;
- SG are more effective when the patient is accompanied by a
caregiver/clinician;
- some SG can be used alone;
- Home-based training is still challenging due to technical issues.
How often should SG be used?
- Training frequency between two and four times a week were rated as the
most adapted; But
- Frequency of use for SG should be personalized based on the game features
and the patient’s clinical profile and motivation;
- Clinician follow up is crucial to keep the SG motivating (no loss of interest, no
addiction).
played alone (e.g., Manera et al., 2015) and with a clinician (Ben-
Sadoun et al., 2016). Ongoing studies are also exploring the
efficacy of ICT-based devices (e.g., avatars, contextual helps) in
supporting older adults with SG use, showing initial promising
results.
What Should Be the Target?
Assessment, training and promoting wellbeing were all rated
as good targets for SG in people with MCI and dementia.
Similarly, in the 2014 recommendations, assessment, stimulation
and rehabilitation were all rated as good targets for people with
AD and related disorders. Favoring social exchanges was not
considered as the best target because most of the existing SG
for older adults are not social (i.e., they are designed for a
single player). However, emerging SG are also targeting the social
domain. Some of these SG are showing promising results (Ben-
Sadoun et al., unpublished data). Training targeting the cognitive
domain and teaching contents may be more suitable to people
with MCI compared to people with dementia, as they require
some intact learning abilities to be optimized. However, beyond
the selection of a clinical target for each patient’s category, an
important aspect to take into account is that the selection of
a SG should be personalized, and based on extensive clinical
assessments aiming at identifying primary and secondary targets
in the cognitive, motivational and emotional domains for each
patient (Mishra et al., 2016). The assessment can also help
to define the main follow up parameters, and the kind of
feedback needed by each patient based on his/her challenges.
For all conditions, SG should ultimately aim at targeting
improvements in daily activities (autonomy). In other words,
improvements in game activities should generalize to untrained
abilities (Anguera et al., 2013), and demonstrate an impact on
real life. SG design principles, such as inclusion of long-term
goals embedded in a cohesive narrative instruction, and of
specific generalization activities (e.g., instructional supports),
may be important for encouraging transfer of knowledge from
the computer to in-person settings. However, even improving
autonomy in the SG activity alone could have a positive impact on
motivation and quality of life: indeed the need of autonomy is one
of the main drivers of the intrinsic motivation to play videogames
in younger people (Deci and Ryan, 2000; Przybylski et al., 2010).
This does not necessarily extend to people with ND. Is the need
of autonomy the main motivational driver also for older adults
with cognitive impairment, or are there other needs (e.g., social
satisfaction/recognition)? To advance the work in this area, more
research should be devoted to the design of SG in these target
populations (De Schutter and Vanden Abeele, 2015).
Where Should SG Be Used, and with
Whom?
The experts suggested that most of the SG are more effective
when the patient is accompanied by a trained caregiver (similarly,
in the 2014 paper, SG were rated as more adapted for use with
a family/professional caregiver, or a healthcare professional).
This is consistent with the general recommendations on SG
usability drafted by Alvarez et al. (2012) who suggested the
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importance of assisting the player to improve his/her game
understanding (how to play?) and motivation (why to play?).
The presence of a caregiver is considered as more important
for people with dementia compared to people with MCI, due
to their lower degree of autonomy. The presence of a trained
person is important for different reasons, including: to motivate
people to use the game; to help progressing in the game
scenario (in case people get stuck), reminding them about game
rules and commands; to make sure the SG are played safely,
especially for physical SG; and to embed the SG in a positive
social and emotional context. The fact that the presence of a
caregiver represents a key element in SG adoption raises potential
ecological and economical barriers to the use of SG outside the
research and clinical context. Possible solutions include involving
a family caregiver, organizing SG group sessions, or providing
remote assistance. Avatars and other game assistance solutions
may also be useful to promote independent SG use in people with
cognitive impairment (Phan Tran et al., unpublished results).
Concerning the Where question, most of the SG are
considered as useful to be delivered both at home and in
clinical facilities. Clinical facilities have the advantage to allow
a complete standardization of the training, and to provide a
secure, controlled environment. The main problem, however, is
represented by the travel time and costs. In order to improve
study adherence, Ben-Sadoun et al. (2016) used a taxi to transport
patients to the clinical facility, resulting in a 100% adherence to
the training. This strategy was also used by Maillot et al. (2012) for
some of elderly subjects which came to the clinical facility during
their Exergame training study. Although this is feasible in the
context of a clinical study, it would be important, in the long term,
to bring SG in the patient’s home for the classical care. At present
home-based training is still challenging due to technical issues
(e.g., hardware setup, availability of an internet connection for
data transfer), and to difficulties to monitor the training remotely,
raising possible security problems. As technologies improve every
day, well-designed feasibility studies in home-based setting are
urgently needed to verify if home-based stimulation is safe and
feasible, and for which patient populations. This is particularly
relevant because new generations of older adults will be more
and more used to employ ICT at home, thus potentially reducing
usability problems.
How Often Should SG Be Used?
Training frequencies between two and four times a week were
rated as the most adapted for people with MCI and dementia.
Evidence collected in recent studies on both cognitive and
cognitive-physical training converges with this recommendation
(e.g., Anguera et al., 2013; Ben-Sadoun et al., 2016). However,
these frequencies should be interpreted with caution. The
frequency of use for specific SG should vary depending on a
number of variables, including the presence of physical activity
(and its intensity), the duration of each game session, the time
that patient (and eventually the caregiver) can devote to the
activity, and the motivation to play. To maximize the training
efficacy, it is important to establish the session frequency and
duration (as well as the total training duration) based on the
goals that the training is willing to achieve, and on the person’s
features. For instance, if the target for a patient is to improve
the general physical fitness, a short intense Exergame training is
probably less adapted compared to a long training with regular
sessions, in which physical activity is progressively increased
based on performance improvements. But the session duration
and goals need to be adapted to the person’s baseline physical
fitness level, taking into account eventual physical constraints
and concurrent pathologies (for instance, the training designed
for an ex-marathon runner should be radically different from
the training for a smoker whose previous level of active physical
activity was limited).
Another crucial aspect to take into account when designing
training is the motivation aspect. In general, the longer and more
intense the training, the better. However, ‘forcing’ employing
the SG too often may result in lowered motivation, or even
in addiction, as there is a fine line between motivational and
addictive aspects (Smith et al., 2011). Ideally, the features of
the training should be adapted in order to increase the patient’s
motivation to play, thus optimizing the training results. Strategies
to improve motivation include, for instance, the presence of a
clinician motivating the person, helping to set the training pace,
and modifying its frequency in a timely manner based on the
patient’s changes; the design of an adaptive game challenge, that
keeps the player in the ‘flow zone’ (the feeling of complete and
energized focus in an activity, with a high level of enjoyment and
fulfillment) and improve the feeling of self-efficacy; for instance,
the game becomes more difficult as the player progresses, but
steps back to an easier level when the player is tired or show a
decline in performance; or the presence of a well-designed game
reward system.
LIMITATIONS
The present recommendations were gathered from a relatively
small group of experts working in the domain of SG for health.
In further work, it would be interesting to verify if these results
hold for a wider expert population (e.g., through web-survey).
Furthermore, it would be interesting to collect the opinion of
healthcare professionals who do not work with SG and ICT
in their practice, to verify the barriers for SG adoption in the
healthcare domain. For instance, if clinicians non-expert in ICT
consider SG as not adapted and not useful for people with ND,
they will hardly suggest their use for training purposes. This
means that more effort should be made to share the promising
results of SG in these populations among the clinical community.
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